All In MedTech

FDA Clearance Tracker · P990027-S018

TECHNOLAS PERFECT VISION 217Z ZYOPTIX SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 17, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 17, 2013

Approved

Time to decision

381 days

Received May 1, 2012. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P990027-S018
Device name
TECHNOLAS PERFECT VISION 217Z ZYOPTIX SYSTEM
Applicant location
MüNchen
Received
May 1, 2012
Decided
May 17, 2013
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P990027

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code LZS

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ADDITION OF THE ADVANCED PLANOSCAN SOFTWARE TO BE USED WITH THE DEVICE.

Source documents

Other decisions for Technolas Perfect Vision GmbH

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.